Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

84 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Active, Not Recruiting

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

NCT03229200

Conditions
Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center Burbank, California, United States
  • City Of Hope National Medical Center Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
View all 98 locations
View Trial Details
Active, Not Recruiting

Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

NCT05263583

Conditions
Burkitt Lymphoma, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +24 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Henan Cancer Hospital Henan, China
  • Shanghai East Hospital Pudong, China
View Trial Details
Active, Not Recruiting

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL

NCT03620578

Conditions
BCL-2 Translocation, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +11 more
Locations
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Leuven-UZLEUVEN Leuven, Belgium
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almere-FLEVOZIEKENHUIS Almere Stad, Netherlands
View all 24 locations
View Trial Details

Related conditions